Skip to Main Content

Author Details

Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
1996
256
66
PMIDPaper TitleJournal TitlePublished Year
36241862Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.J Cancer Res Clin Oncol2023
37656784BRAF<sup>οβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability.Sci Adv2023
37481390Long-term quality of life after resection of retroperitoneal soft tissue sarcoma.Eur J Surg Oncol2023
37544709Tumour mutational burden and survival with molecularly matched therapy.Eur J Cancer2023
37690178A 3-dimensional histology computer model of malignant melanoma and its implications for digital pathology.Eur J Cancer2023
37734378Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.Cell Rep Med2023
37641393Precision cancer medicine: Concepts, current practice, and future developments.J Intern Med2023
37532709Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.Nat Commun2023
37455247Implementation of precision medicine in healthcare-A European perspective.J Intern Med2023
37382622A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma.World J Urol2023
37280276The German Network for Personalized Medicine to enhance patient care and translational research.Nat Med2023
37406166Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.Blood Adv2023
37101762Palbociclib in Acute Leukemias With <i>KMT2A</i>-rearrangement: Results of AMLSG 23-14 Trial.Hemasphere2023
37327584Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).Transl Oncol2023
37260092Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study.Eur J Endocrinol2023
36888935National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine.JCO Clin Cancer Inform2023
36852573Real-world data for precision cancer medicine-A European perspective.Genes Chromosomes Cancer2023
36808802Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling.Mol Oncol2023
36470093Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study.Eur J Cancer2023
36434139The coming decade in precision oncology: six riddles.Nat Rev Cancer2023
36702933Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.Nat Cancer2023
36759549Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing.Sci Rep2023
34331337Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.Genes Chromosomes Cancer2022
35643220Biology-guided precision medicine in rare cancers: Lessons from sarcomas and neuroendocrine tumours.Semin Cancer Biol2022
35763870Gene expression-based prediction of pazopanib efficacy in sarcoma.Eur J Cancer2022
35668118MCL1 as putative target in pancreatoblastoma.Virchows Arch2022
35497498BTB<sub>BCL6</sub> dimers as building blocks for reversible drug-induced protein oligomerization.Cell Rep Methods2022
35366909Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations.J Transl Med2022
35599019Application of precision medicine in clinical routine in haematology-Challenges and opportunities.J Intern Med2022
35459264Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.Oncogenesis2022
35597437Precision medicine in cancer: A paradigm shift.Semin Cancer Biol2022
35563565Recurrent Germline Variant in <i>RAD21</i> Predisposes Children to Lymphoblastic Leukemia or Lymphoma.Int J Mol Sci2022
35390650Explainable artificial intelligence in skin cancer recognition: A systematic review.Eur J Cancer2022
35781181Response to letter entitled: Re: Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review.Eur J Cancer2022
35621918MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.Mol Oncol2022
35681079Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).NPJ Precis Oncol2022
36480778Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.JCO Precis Oncol2022
36495861Toward defining the clinically actionable genome of metastatic breast cancer.Med2022
35973360Model soups improve performance of dermoscopic skin cancer classifiers.Eur J Cancer2022
35871236Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.Br J Cancer2022
36274133Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards.BMC Med2022
35864412Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.J Neurooncol2022
35983950Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.Liver Int2022
35887198Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors.Int J Mol Sci2022
35918329Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.Nat Commun2022
35916701Uncertainty Estimation in Medical Image Classification: Systematic Review.JMIR Med Inform2022
36252999IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells.J Immunother Cancer2022
35976907Deep learning can predict survival directly from histology in clear cell renal cell carcinoma.PLoS One2022
33581189Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists.J Am Acad Dermatol2022
35188570ALT-FISH quantifies alternative lengthening of telomeres activity by imaging of single-stranded repeats.Nucleic Acids Res2022
  • 1 - 50 of 256

Recommended Authors

Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 6
Mara Rosenberg
Broad Institute of MIT and Harvard
Career Start Year 2013
Number of shared co-authors 20
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 6
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 12
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 9
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 4
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 1
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 5
Kilannin Krysiak
Washington University School of Medicine
Career Start Year 2007
Number of shared co-authors 8
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 11
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 2
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 9
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 10
Peter J Campbell
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 41
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 7
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 3
Fei Yang
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 5
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 3
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 43
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 6
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 5
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 12
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 3
Kimberly Stegmaier
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 31
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 18
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 3
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 42
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 22
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 6
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 7

Collaborators

Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 72
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers 43
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 42
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 39
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 37
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 36
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 30
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 24
Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Co-authored papers 22
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 22
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 20
Dirk Schadendorf
Co-authored papers 19
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 18
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 17
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 16
Daniel Kazdal
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 14
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 13
Anna-Lena Volckmar
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 12
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 12
Matthias Schlesner
University of Augsburg
Co-authored papers 10
Andreas von Deimling
Co-authored papers 9
Stephan Wolf
Co-authored papers 9
Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers 8
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 8
Brian J P Huntly
University of Cambridge
Co-authored papers 7
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Co-authored papers 6
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 5
Nikolas von Bubnoff
University Hospital of Schleswig-Holstein
Co-authored papers 5
Release 1.2